Faculty News

Michael Gottesman and Ira Pastan featured in NIH Intramural Research Program podcast

Michael Gottesman, M.D., Chief of the Laboratory of Cell Biology, and Ira Pastan, M.D., Co-Chief of the Laboratory of Molecular Biology, were recently featured in the NIH IRP podcast Speaking of Science. In the podcast, Dr. Gottesman and Dr. Pastan discussed how their research and discoveries have helped effectively treat cancer in order to improve and save potentially millions of lives.

Lori Wiener selected as NYU Alumni Changemaker

Lori Wiener, Ph.D., DCSW, LCSW-C, Senior Associate Scientist in the Pediatric Oncology Branch, has been selected as a 2019 NYU Alumni Changemaker. Changemakers are selected by the NYU Alumni Association Board for their ability to reduce suffering, bring hope to the marginalized and save lives.

Steve Rosenberg receives 2019 Edogawa NICHE Prize

Steve Rosenberg, M.D., Ph.D., Chief of the Surgery Branch, has received the 2019 Edogawa NICHE Prize. Dr. Rosenberg was recognized for his pioneering work in developing effective adoptive immunotherapies and genetically modified T cells, which has heralded the birth of a new chapter in the fight against cancer.

James Kochenderfer named finalist for 2019 FNIH Trailblazer Prize for Clinician-Scientists

James N. Kochenderfer, M.D., Investigator in the Surgery Branch, has been selected as a finalist for the Foundation for the National Institutes of Health (FNIH) Trailblazer Prize for Clinician-Scientists. He is nominated for developing immunotherapies that leverage chimeric antigen receptor (CAR) T cells to treat blood cancers, including lymphoma and multiple myeloma. The winner of the Trailblazer Prize will be announced October 23, 2019.

Clinical Trial Conversation: Tim Greten describes primary liver cancer clinical trial

Hepatocellular carcinoma (HCC) is an aggressive form of liver cancer that is very difficult to treat, and patients live an average of six to nine months after diagnosis. Tim Greten, M.D., Deputy Chief of the Thoracic and GI Malignancies Branch, is leading a new clinical trial to determine whether administering the antibiotic vancomycin in combination with the drugs nivolumab and tadalafil will lead to cancer regression in patients with liver metastasis or primary HCC.

Bill Telford receives 2019 International Society for the Advancement of Cytometry Distinguished Service Award

Bill Telford, Ph.D., Senior Associate Scientist in the Experimental Transplantation and Immunology Branch, has received the 2019 International Society for the Advancement of Cytometry (ISAC) Distinguished Service Award. The award honors individuals who served ISAC in a major role, provided major support to ISAC and its members or made a significant contribution to the success of ISAC.

Jack Shern featured in LocalDVM news article

Jack Shern M.D., Investigator in the Pediatric Oncology Branch, was recently featured in a LocalDVM news article focused on Camp Fantastic, a week-long camp for children with cancer. In the article, Dr. Shern discusses his role as medical director of the camp and medical services provided to campers.

Ken Kraemer featured in Associated Press

Ken Kraemer, M.D., Senior Investigator in the Laboratory of Cancer Biology and Genetics, was recently featured in an Associated Press article on xeroderma pigmentosum (XP) prevalence in Morocco. In the article, Dr. Kraemer discussed the magnitude of people affected by XP in North Africa, and his research nurse, Deborah Tamura, discussed practical tips XP support groups shared during a meeting in London last year.

Amy LeBlanc featured in Wired

Amy LeBlanc, D.V.M., Director of the Center for Cancer Research’s Comparative Oncology Program, was recently featured in a Wired article that discusses the role of dogs in human cancer research. In the article, Dr. LeBlanc says that the comparative oncology Cancer Moonshot projects “… are developing very critical, biologically rich information in patients who happen to be dogs.”

Ying Zhang’s research featured in new NIH Intramural Research Program blog

Ying Zhang, Ph.D., Senior Investigator in the Laboratory of Cellular and Molecular Biology, is featured in a new NIH Intramural Research Program blog post. The blog post, “Scientific Detour Advances Understanding of Fatty Liver Disease," focuses on Dr. Zhang’s research, including a recent study that could eventually lead to preventing or reversing unhealthy amounts of fat storage in the liver.

Breadcrumb